Halcyon Days For Investors -- November 5, 2021

Fed hike: tea leaves now suggest first rate hike won't occur before 1Q23. That's the first quarter of 2023. That's more than a year from now. No rate increases all next year (2022): tea leaves. 

SRE: beats by one penny; beats on revenue; shares; extends losses in pre-market trading;

Pre-market: records from earlier this week are holding in pre-market

• three major US equity indices all in the green
• selected tickers:

• MPC: down slightly at close yesterday; flat pre-market;
• AAPL: down a bit at close yesterday; up slightly this morning;
• UNP: down almost one percent yesterday (ouch -- profit taking); today, up a bit;
• SRE: down yesterday; down more today;
• OKE: down yesterday; up a bit
• CLR: down 5% yesterday; up 1.32% in pre-market trading today
• DVN: up 1% yesterday; up another 1.3% now
• XLNX: on a tear; up 3.43% yesterday; up another 1.85% in pre-market trading; might XLNX hit $200 today?
  
• oral anti-covid drugs
• huge breakthrough: will affect other viral diseases
• anti-covid drugs tested on unvaccinated patients only
• comparison with ivermectin not mentioned
  
• MRK: up yesterday; down now; first to announce drug; earlier this week;
  
• PFE: down yesterday; up over 8% in pre-market trading; announced very effective drug overnight;
  

Covid-19: are folks paying attention. Huge strides in anti-viral research and results being reported. Huge. Previously posted on the blog: Covid-19: many, many silver linings to this dark cloud. Overall: something "positive" for humanity.